Full metadata record
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technologyen_US
dc.contributor.advisorWong, Wing Tak (ABCT)en_US
dc.creatorChan, Brandon Dow-
dc.identifier.urihttps://theses.lib.polyu.edu.hk/handle/200/12230-
dc.languageEnglishen_US
dc.publisherHong Kong Polytechnic Universityen_US
dc.rightsAll rights reserveden_US
dc.titleThe dual functional anti-angiogenic and anti-inflammatory peptide DA4 as a therapeutic against diabetic retinopathyen_US
dcterms.abstractDiabetic retinopathy (DR) has been suggested to be the most common microvascular complication of diabetes, and is the leading cause of vision loss and blindness among adults, worldwide. In 2020 there were an estimated 103.1 million adults with DR, with cases projected to rise to 160.5 million by 2045. Due to a globally aging population, increased life expectancy of those with diabetes, and increased risk for diabetes due to lifestyle and dietary trends, the burden of DR is only expected to increase in the coming years. Thus, there is a pressing need for the discovery and development of novel and effective therapies against DR.en_US
dcterms.abstractSnake venoms are regarded as a rich natural source for the discovery of biologically active molecules with diverse effects. In our work, we first set out to mine the anti-angiogenic potential of a novel peptide, DA4, isolated from the venom of the snake Deinagkistrodon acutus. We demonstrated that DA4 exhibited potent in vitro and in vivo anti-angiogenic effects. Mechanistically, the anti-angiogenic activity of DA4 was proposed to involve induction of TIMP3, which inhibited VEGF signaling, and downstream cell migratory and cell proliferative mediators such as Erk1/2, eNOS, p38, LIMK/cofilin, and Hsp27. PPP3R2 and SH2D2A, angiogenic components of the VEGF-induced signaling cascade, were also downregulated by DA4.en_US
dcterms.abstractDue to the inter-related nature of angiogenesis and inflammation, in the second part of our study, we investigated the potential anti-inflammatory effects of DA4. In vitro, we demonstrated that DA4 could inhibit major pro-inflammatory signaling pathways, including the NF-kB, MAPK, and STAT3 signaling pathways. Further, we showed that DA4 could inhibit the NLRP3 inflammasome signaling pathway, via suppression of NLRP3 gene expression. Through experiments in two different inflammation mouse models, we demonstrated the in vivo anti-inflammatory efficacy of DA4, which was comparable to other commonly used chemical inhibitors of inflammation.en_US
dcterms.abstractIn the third part of the study, we investigated the therapeutic efficacy of DA4 against diabetic retinopathy, a disease where both angiogenesis and inflammation are of key importance. DA4 showed therapeutic efficacy in three different diabetic mouse models, with amelioration of key DR-related characteristic features. The anti-angiogenic and anti-inflammatory activity of DA4 was also confirmed in the retinas of DR model mice. Although retinal cell and visual function were not shown to be improved by treatment with DA4, no deleterious effects were seen.en_US
dcterms.abstractIn the last part of the study, we developed and optimized a bacteria-based platform for production and purification of recombinant DA4. Functional assessments indicated that the anti-angiogenic and anti-inflammatory activity of purified recombinant DA4 was comparable to naturally isolated DA4, indicating the viability for its use in downstream in vitro and in vivo studies.en_US
dcterms.abstractAltogether, the work in this thesis presents for the first time, the anti-angiogenic and anti-inflammatory effects of the novel snake venom peptide, and its therapeutic potential against diabetic retinopathy.en_US
dcterms.extentxxi, 250 pages : color illustrationsen_US
dcterms.isPartOfPolyU Electronic Thesesen_US
dcterms.issued2022en_US
dcterms.educationalLevelPh.D.en_US
dcterms.educationalLevelAll Doctorateen_US
dcterms.LCSHDiabetic retinopathyen_US
dcterms.LCSHPoisonous snakes -- Venomen_US
dcterms.LCSHHong Kong Polytechnic University -- Dissertationsen_US
dcterms.accessRightsopen accessen_US

Files in This Item:
File Description SizeFormat 
6638.pdfFor All Users9.17 MBAdobe PDFView/Open


Copyright Undertaking

As a bona fide Library user, I declare that:

  1. I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
  2. I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
  3. I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.

By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.

Show simple item record

Please use this identifier to cite or link to this item: https://theses.lib.polyu.edu.hk/handle/200/12230